We hope that you are as excited as us to be attending the BSBR in early November.

As part of our support of the meeting we would like to personally invite you to have a hands-on try of our soon to be launched NeoNavia Biopsy System.

Available during breaks throughout the meeting you will have the opportunity to gain first-hand experience of our patented micro-pulse technology, designed to allow more precise lesion targeting and improved sample yield to aid correct diagnosis and individualised treatment.

We would love for you to experience our technology first-hand and hope you can join us in one of the breaks.
Attendance will be limited, and places held on a first come, first served basis so please book your place now.

Please contact the Conference Organisers if you would like to book a 30 minute time slot:


10:45 – 11:15      13:00 – 13:30 


08:00 – 08:30      09:45 – 10:15      12:45 – 13:15


About us; NeoDynamics AB is a Swedish Med-Tech company dedicated to advancing diagnosis and care of breast cancer. The company has an innovative biopsy system, NeoNavia®, in late stage development. The precision biopsy system is built on patented micro-pulse technology, based on research at the Karolinska Institute in Sweden.

The system is designed to offer clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment. NeoNavia® is being evaluated at leading clinics in the UK, Germany and Sweden with a commercial launch expected in 2020.

The NeoNavia® biopsy system will be available to try during breakout sessions so please visit us to understand more.

We look forward to welcoming you.

Best wishes

Ian Galloway

Country Manager UK on behalf of the NeoDynamics team